Key Points
Israeli and US researchers have developed an antibody-based treatment that empowers the bodys immune system to effectively attack cancer cells and prevent their spread, Israels Weizmann Institute of Science (WIS) said in a statement on Monday.. WIS-led scientists revealed that a form of breast cancer known as triple-negative breast cancer encourages nearby immune cells to form molecular bridges..
The research team demonstrated that an antibody treatment blocking the formation of these bridges can revive the immune systems ability to mount a robust attack on cancer cells, halting tumour progression in mouse models..
They explained that while the breast cancer cells themselves express very low levels of the protein CD84, which is used to build the bridges, they induce nearby immune cells to produce large quantities of this protein, creating the bridges that suppress the immune response...
You might be interested in
How new antibody can target and cure melanomas: Study
26, Apr, 23Melanoma - one of the most aggressive types of cancer, can be targetted with a new type of immunotherapy. | Health
Why some tumour cells become resistant to chemotherapy: Researchers reveal
07, Mar, 23Chemotherapy is still the primary treatment for the majority of tumours, making it a core problem in cancer research to understand why some tumour cells develop resistance to it. | Health